Grace Therapeutics (NASDAQ:GRCE) Issues Quarterly Earnings Results

Grace Therapeutics (NASDAQ:GRCE) issued its quarterly earnings results on Thursday. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.04, FiscalAI reports.

Grace Therapeutics Stock Down 1.1%

Shares of Grace Therapeutics stock traded down $0.02 during trading on Thursday, reaching $1.83. The company’s stock had a trading volume of 72,594 shares, compared to its average volume of 345,710. Grace Therapeutics has a 52-week low of $1.67 and a 52-week high of $5.18. The firm’s 50-day moving average is $2.02 and its two-hundred day moving average is $2.76. The company has a market cap of $38.60 million, a price-to-earnings ratio of -1.56 and a beta of 0.43.

Analyst Upgrades and Downgrades

GRCE has been the topic of several recent research reports. Zacks Research upgraded Grace Therapeutics to a “hold” rating in a research report on Monday, August 3rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Grace Therapeutics in a report on Thursday, October 15th. Finally, Wall Street Zen downgraded Grace Therapeutics from a “sell” rating to a “strong sell” rating in a research report on Saturday, November 7th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Grace Therapeutics has an average rating of “Hold” and an average price target of $6.00.

Grace Therapeutics Company Profile

Grace Therapeutics, Inc. (NASDAQ: GRCE) is a clinical-stage biopharmaceutical company developing therapies for rare and life-threatening medical conditions. The company focuses on drug-delivery technologies intended to improve the administration, absorption, and therapeutic performance of established pharmaceutical compounds. Grace Therapeutics’ lead candidate is GTx-104, an investigational injectable formulation of nimodipine being developed for patients with aneurysmal subarachnoid hemorrhage, a serious form of bleeding around the brain.